InvestorsHub Logo
icon url

riaguy

08/07/17 11:01 PM

#114359 RE: falconer66a #114349

Great find
icon url

nidan7500

08/08/17 8:00 AM

#114375 RE: falconer66a #114349

Is this any kind of indicator for when the FDA releases new trial guidance? Curious, a possibility. The sooner the better.

Abstract: The Anavex Presentation

Daniel Klamer, Vice President, Business Development & Scientific Strategy
Anavex Life Sciences

10th CNS PARTNERING & DEAL-MAKING
SEPTEMBER 11-12, 2017 BOSTON, MA

icon url

baltimorebullet

08/08/17 10:04 AM

#114391 RE: falconer66a #114349

I'd be shocked if we don't hear mention of a MS trial soon.


The scientific rationale, preclinical data, and clinical development path of ANAVEX 2-73 as a novel treatment strategy for Rett Syndrome, Parkinson’s Disease, and Multiple Sclerosis will be discussed in more detail. This presentation will explore the links between preclinical findings and clinical trial development trajectory in our ongoing translational research efforts.
icon url

mrplmer

08/08/17 5:48 PM

#114498 RE: falconer66a #114349

So Danny has to pimp this mountain mover? Wow. Speaks volumes.